Literature DB >> 26300206

Rivaroxaban-induced hair loss.

Basile Chrétien1, Anne Besnard1, Marion Sassier1, Claire Le Hello2, Antoine Coquerel1,3,4, Joachim Alexandre1,3,5,6, Sophie Fedrizzi7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26300206     DOI： 10.1007/s00228-015-1927-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  3 in total

1.  Warfarin-induced alopecia after repeated chemotherapy.

Authors:  Satoshi Nakamizo; Gyohei Egawa; Akiko Arakawa; Yoshiki Miyachi; Kenji Kabashima
Journal:  Eur J Dermatol       Date:  2010-10-12       Impact factor: 3.328

Review 2.  Drugs and hair loss.

Authors:  Mansi Patel; Shannon Harrison; Rodney Sinclair
Journal:  Dermatol Clin       Date:  2012-09-18       Impact factor: 3.478

Review 3.  Telogen effluvium.

Authors:  S Harrison; R Sinclair
Journal:  Clin Exp Dermatol       Date:  2002-07       Impact factor: 3.470
  3 in total
  4 in total

1.  Direct-acting oral anticoagulants and alopecia: The valuable support of postmarketing data.

Authors:  Giulia Bonaldo; Alberto Vaccheri; Domenico Motola
Journal:  Br J Clin Pharmacol       Date:  2020-02-18       Impact factor: 4.335

Review 2.  Alopecia in anticoagulated patients.

Authors:  Marcos Arêas Marques; Carmen Lucia Lascasas Porto; Ana Letícia de Matos Milhomens; Juliana de Miranda Vieira; Claudia Carvalho Alcântara Gomes; Ana Thereza Cavalcanti Rocha; Cíntia da Silva Miller
Journal:  J Vasc Bras       Date:  2020-06-08

3.  Non-hemorrhage-related adverse effects of rivaroxaban.

Authors:  Eliza C Christopoulou; Theodosios D Filippatos; Moses S Elisaf
Journal:  Arch Med Sci Atheroscler Dis       Date:  2017-12-31

4.  Agent specific effects of anticoagulant induced alopecia.

Authors:  Angela C Weyand; Jordan A Shavit
Journal:  Res Pract Thromb Haemost       Date:  2017-05-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.